Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 3, 2006, Pages 245-250

  Peirano, Gisele ^a   Dos Santos Souza, Flávia ^a   Dos Prazeres Rodrigues, Dalia ^a   Proeitti Jr , Aldo ^b   Camilo, Cecília ^c   Cosme, Lécia Maria S S ^c   Fontana, Christine K ^c   Rodrigues, Dauri S ^c   Miralles, Iracema S ^c   Cavalcante, Valdelúcia O ^c   Souza, Maria Da Penha A H ^c   Huf, Hilda Maria R ^c   Gomes, Marizoneide ^c   Coelho, Marinalva ^d   Lourenço, Maria Cristina ^e  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Public Health Laboratory PHL AP

^c PHL/RR ^*

^d Children Reference Hospital PE

^e Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Antimicrobial resistance surveillance; Brazil; Serovars; Shigella

Indexed keywords

SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

EID: 33745493255     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000300003     Document Type: Article

References (33)

1. Almeida MTG, Silva RM, Donaire LM, Moreira LE, Martinez MB 1998. Enteropathogens associated with acute diarrheal disease in children. J Pediatr 74: 291-298.
2. Anonymous 2004. Antibiotics in the management of shigellosis. Wkly Epidemiol Rec 79: 355-356.
3. Ashkenazi S 2004. Shigella infection in children: new insights. Sem Pediatr Infect Dis 15: 246-252.
4. Ashkenazi S, Levy I, Kazaronovski V, Samra Z 2003. Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother 51: 427-429.
5. Basualdo W, Arbo A 2003. Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediatr Infect Dis J 22: 374-377.
6. Bhattacharya SK, Sur D 2003. An evaluation of current shigellosis treatment. Expert Opin Pharmacother 4: 1315-1320.
7. Bopp CA, Brenner FW, Fields PI, Wells JG, Strockbine NA 2003. Escherichia, Shigella, and Salmonella. In PR Murray, EJ Baron, JH Jorgensen, MA Pfaller, RH Yolken (eds), Manual of Clinical Microbiology, 7th ed., American Society of Microbiology, Washington DC, p. 654-671.
8. CDC-Centers for Disease Control and Prevention 2004. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): 2002 Human Isolates Final Report. Atlanta, Georgia: US Department of Health and Human Services, CDC. Available at http://www.cdc.gov/narms/annual/2002/ 2002ANNUALREPORTFINAL.pdf.
9. Cheasty T, Skinner JA, Rowe B, Threlfall EJ 1998. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy. Microb Drug Resist 4: 57-60.
10. Diniz-Santos DR, Santana JS, Barretto JR, Andrade MGM, Silva LR 2005. Epidemiological and microbiological aspects of acute bacterial diarrhea in children from Salvador, Bahia, Brazil. Braz J Infect Dis 9: 77-83.
11. Egah DZ, Banwat EB, Audu ES, Allanana JA, Danung ML, Damen JG, Badung BP 2003. Multiple drug resistant strains of Shigella isolated in Jos, central Nigeria. Niger Postgrad Med J 10: 154-156.
12. Fulla N, Prado V, Duran C, Lagos R, Levine MM 2005. Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am J Trop Med Hyg 72: 851-854.
13. Jeong YS, Lee JC, Kang HY, Yu HS, Lee EY, Choi CH, Tae SH, Lee YC, Cho DT, Seol SY 2003. Epidemiology of nalidixic acid resistance and TEM-1 and TEM-52-mediated ampicillin resistance of Shigella sonnei isolates obtained in Korea between 1980 and 2000. Antimicrob Agents Chemother 47: 3719-3723.
14. Jones FR, Sanchez JL, Meza R, Batsel TM, Burga R, Canal E, Block K, Perez J, Bautista CT, Escobedo J, Walz SE 2004. Short report: High incidence of shigellosis among Peruvian soldiers deployed in the Amazon River basin. Am J Trop Med Hyg 70: 663-665.
15. Khan AI, Huq S, Malek MA, Hossain MI, Talukder KA, Faruque AS, Salam MA, Sack DA 2004. Shigella serotypes among hospitalized patients in urban Bangladesh and their antimicrobial resistance. Epidemiol Infect 132: 773-777.
16. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull WHO 77: 651-666.
17. Lee JC, Oh JY, Kim KS, Jeong YW, Cho JW, Park JC, Seol SY, Cho DT 2001. Antimicrobial resistance of Shigella sonnei in Korea during the last two decades. APMIS 109: 228-234.
18. Lima AAM, Lima NL, Pinho MCN, Barros Junior EA, Teixeira MJ, Martins MCV, Guerrant RL 1995. High frequency of strains multiply resistant to ampicillin, trimethoprimsulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993. Antimicrob Agents Chemother 39: 256-259.
19. Maraki S, Georgiladakis A, Christidou A, Scoulica E, Tselentis Y 1998. Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 1991-1995. APMIS 106: 879-883.
20. Medeiros MIC, Neme SM, Silva P, Capuano DM, Errera MC, Fernandes SA, Valle GR, Ávila FA 2001. Etiology of acute diarrhea among children in Ribeirão Preto-SP, Brazil. Rev Inst Med Trop São Paulo 43: 21-24.
21. Merino LA, Hrenuk GE, Ronconi MC, Alonso JM 2004. Antibiotic resistance and molecular epidemiology of Shigella spp. in northeastern Argentina. Rev Panam Salud Publica 15: 219-224.
22. NCCLS-National Committee for Clinical Laboratory Standards 2003. Performance Standard for Antimicrobial Disk Susceptibility Tests. Approved Standard, 8th ed., Wayne, PA, NCCLS document M2-A8.
23. Niyogi SK 2005. Shigellosis. J Microbiol 43: 133-143.
24. Niyogi SK, Mitra U, Dutta P 2001. Changing pattern of serotypes, antimicrobial susceptibilities of Shigella species isolated from children in Calcutta. Jpn J Infect Dis 54: 121-122.
25. Radice M, González C, Power P, Vidal MC, Gutkind G 2001. Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg Infect Dis 7: 1-2.
26. Rodrigues DP 2000. Surveillance of antimicrobial resistance in bacterial enteropathogens isolated in Brazil. In R Salvatierra-Gonzales, Y Benguigui (eds), Antimicrobial Resistance in the Americas: Magnitude and Containment of the Problem. PAHO/HGP/HCT/163/2000.
27. Santos BA, Pires AA, Souza ARM, Vives C, Barcellos S, Bo DJD 1997. Study of in vitro antimicrobial resistance of positive coprocultures to Shigella sp. J Pediatr 73: 395-400.
28. Sarkar K, Ghosh S, Niyogi SK, Bhattacharya SK 2003. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones. Lancet 361: 785.
29. Simmons DA, Romanowska E 1987. Structure and biology of Shigella flexneri O antigens. J Med Microbiol Rev 23: 289-302.
30. Souza FS 2001. Study of Characteristics Phenotypics and Genotypics in Shigella flexneri, Fundação Oswaldo Cruz, Rio de Janeiro, 104 pp.
31. Sur D, Niyogi SK, Sur S, Datta KK, Takeda Y, Nair GB, Bhattacharya SK 2003. Multidrug-resistant Shigella dysenteriae type 1: forerunners of a new epidemic strain in Eastern India? Emerg Infect Dis 9: 404-405.
32. Sur D, Ramamurthy T, Deen J, Bhattacharya SK 2004. Shigellosis: challenges and management issues. Indian J Med Res 120: 454-462.
33. WHO-World Health Organization 2001. Antimicrobial resistance in shigellosis, cholera, and campylobacteriosis.WHO/CDS/CSR/DRS/2001.8, Geneva.